Novavax booster shot decision surprises experts

Sep 9, 2021 | News, NZ Covid-19, Vaccines

Top vaccine experts have been blindsided by confirmation Novavax has firmed as the favourite to be used in next year’s mass Covid-19 booster programme with no strong evidence confirming New Zealanders will need a third vaccine dose.

Fran Priddy​, the clinical evaluation director at Malaghan Institute and Vaccine Alliance Aotearoa New Zealand’s clinical director, only found out through Stuff that 5.36 million courses of Novavax vaccine, which is yet to gain Medsafe approval, are due early next year, likely as part of a mass booster programme.

University of Auckland vaccinologist Helen Petousis-Harris,​ who has advised the WHO on vaccines, also found out through the media.

Read full article here
Source: Stuff

Spread the news